Skip to content
Independent analysis of NHS open data
PharmaInsight

Rinvoq 45mg modified-release tablets

1001030AEBBACAC · Musculoskeletal and Joint Diseases
Data updated May 2026
1items

Dispensed in May 2026

NHSBSA Prescription Cost Analysis

£2,087

Net ingredient cost · May 2026

NHSBSA PCA

1items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Rinvoq 45mg modified-release tablets: national items dispensed by month

0 1 2 Jul 2023 Nov 2023 Aug 2024 May 2026 1 Jul 2023: 1 Sep 2023: 2 Nov 2023: 1 Jan 2024: 1 Aug 2024: 1 Jan 2025: 2 Feb 2025: 1 May 2026: 1

Source: NHSBSA Prescription Cost Analysis, to May 2026

One presentation of Upadacitinib. See the chemical for the full national picture and related presentations.